Skip to main content

Teva leaves lobbying group


NEW YORK Teva is planning to leave the Generic Pharmaceutical Association this summer, saying the organization is no longer capable of reflecting the company’s interests, according to published reports.

Teva, based in Israel, has grown to become the world’s largest manufacturer of generic drugs and is the only generics-focused company on IMS Health’s list of the top 15 drug makers worldwide, ranking above Bayer, Boehringer Ingelheim, Amgen and Takeda. Teva North America president and CEO William Marth served two terms as GPhA’s chairman, from 2008 to February of this year, and has served on the organization’s board since 2005.

A GPhA spokeswoman declined to provide comment on the matter.

This ad will auto-close in 10 seconds